GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID
HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL
MORTALITY: 1 YEAR FOLLOW-UP

a 2022

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

NGUYEN, T.N., M.M. QURESHI, P. KLEIN, Robert MIKULÍK, H. YAMAGAMI et. al.

Basic information

Original name

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

Name (in English)

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

Authors

NGUYEN, T.N. (guarantor), M.M. QURESHI, P. KLEIN, Robert MIKULÍK (203 Czech Republic, belonging to the institution), H. YAMAGAMI, N. ETMINAN, A. SATHYA, M. ABDALKADER, E Saxhaug KRISTOFFERSEN, O.Y. MANSOUR, J. DEMEESTERE, K. ALPAY, H. LO, O. NAGGARA, M.A. MOHLENBRUCH, M. ACAMPA, G.M. KARWACKI, S. AHMAD, T.D. MAI, C. FALUP-PECURARIU and at. ALL

Edition

ESOC 2022, 2022

Other information

Language

Czech

Type of outcome

Konferenční abstrakt

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

PDF URL

Impact factor

Impact factor: 6.100

RIV identification code

RIV/00216224:14110/22:00127797

Organization unit

Faculty of Medicine

ISSN

DOI

http://dx.doi.org/10.1177/23969873221094907

Keywords (in Czech)

subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;

Keywords in English

subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;

Abstract

ORIG EN

V originále

Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.

In English

Links

90128, large research infrastructures

Name: CZECRIN III

Citovat

NGUYEN, T.N., M.M. QURESHI, P. KLEIN, Robert MIKULÍK, H. YAMAGAMI, N. ETMINAN, A. SATHYA, M. ABDALKADER, E Saxhaug KRISTOFFERSEN, O.Y. MANSOUR, J. DEMEESTERE, K. ALPAY, H. LO, O. NAGGARA, M.A. MOHLENBRUCH, M. ACAMPA, G.M. KARWACKI, S. AHMAD, T.D. MAI, C. FALUP-PECURARIU and at. ALL. GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP. In ESOC 2022. 2022. ISSN 2396-9873. Available from: https://dx.doi.org/10.1177/23969873221094907.

@proceedings{2244853,
   author = {Nguyen, T.N. and Qureshi, M.M. and Klein, P. and Mikulík, Robert and Yamagami, H. and Etminan, N. and Sathya, A. and Abdalkader, M. and Kristoffersen, E Saxhaug and Mansour, O.Y. and Demeestere, J. and Alpay, K. and Lo, H. and Naggara, O. and Mohlenbruch, M.A. and Acampa, M. and Karwacki, G.M. and Ahmad, S. and Mai, T.D. and FalupandPecurariu, C. and all, at.},
   booktitle = {ESOC 2022},
   doi = {http://dx.doi.org/10.1177/23969873221094907},
   keywords = {subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;},
   language = {cze},
   title = {GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073159/pdf/10.1177_23969873221094907.pdf},
   year = {2022}
}

TY  - CONF
ID  - 2244853
AU  - Nguyen, T.N. - Qureshi, M.M. - Klein, P. - Mikulík, Robert - Yamagami, H. - Etminan, N. - Sathya, A. - Abdalkader, M. - Kristoffersen, E Saxhaug - Mansour, O.Y. - Demeestere, J. - Alpay, K. - Lo, H. - Naggara, O. - Mohlenbruch, M.A. - Acampa, M. - Karwacki, G.M. - Ahmad, S. - Mai, T.D. - Falup-Pecurariu, C. - all, at.
PY  - 2022
TI  - GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP
KW  - subarachnoid hemorrhage (SAH)
KW  - COVID-19
KW  - ANEURYSM TREATMENT;
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073159/pdf/10.1177_23969873221094907.pdf
N2  - Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.
ER  -

NGUYEN, T.N., M.M. QURESHI, P. KLEIN, Robert MIKULÍK, H. YAMAGAMI, N. ETMINAN, A. SATHYA, M. ABDALKADER, E Saxhaug KRISTOFFERSEN, O.Y. MANSOUR, J. DEMEESTERE, K. ALPAY, H. LO, O. NAGGARA, M.A. MOHLENBRUCH, M. ACAMPA, G.M. KARWACKI, S. AHMAD, T.D. MAI, C. FALUP-PECURARIU and at. ALL. GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP. In \textit{ESOC 2022}. 2022. ISSN~2396-9873. Available from: https://dx.doi.org/10.1177/23969873221094907.

Detailed Information on Publication Record